Stay updated on RGX-111 Gene Therapy in MPS I Clinical Trial
Sign up to get notified when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.

Latest updates to the RGX-111 Gene Therapy in MPS I Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe RGX-111 study record is displayed with its suspended status and FDA clinical hold notice, along with the study design, eligibility criteria, and outcome measures.SummaryDifference54%

- Check16 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide notice announces NIH website updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error instead of the study record.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content. This blocks access to the NCT03580083 record and prevents viewing its details on ClinicalTrials.gov.SummaryDifference19%

Stay in the know with updates to RGX-111 Gene Therapy in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.